- call +1-201-465-4211
- email sales@mrinsights.biz
Radioactive stents are small expandable tubes that are used in prevention of restenosis and coronary artery lesions, and in improving catheter-based revascularization. These stents are widely utilized in cancer treatment as they utilize high-energy gamma rays that destroy the cancer cells and prevent their proliferation.
Scope of the Report:
This report focuses on the Radioactive Stents in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Radioactive Stents is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
C.R. Bard, Inc.
Cook Medical Inc.
Medline Industries Ltd
Pnn Medical A/S
Allium Medical Solutions Ltd.
APC Cardiovascular Ltd.
Micro-Tech Pvt. Ltd.
Changzhou Zhiye Co Ltd.
Aetna Inc.
Abbott Laboratories
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Retrograde Stents
Antegrade Stents
Internal (Double-J) Stents
Iodine-125 Radioactive Stents
Others
Market Segment by Applications, can be divided into
Lithotripsy
Ureteroscopy
Ureteroenoscopy
Percutaneous Nephrolithotomy
Angiography
Neointimal Hyperplasia
Esophageal Cancer
Biliary Cancer
Others
There are 15 Chapters to deeply display the global Radioactive Stents market.
Chapter 1, to describe Radioactive Stents Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Radioactive Stents, with sales, revenue, and price of Radioactive Stents, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Radioactive Stents, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Radioactive Stents market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Radioactive Stents sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Radioactive Stents Introduction
1.2 Market Analysis by Type
1.2.1 Retrograde Stents
1.2.2 Antegrade Stents
1.2.3 Internal (Double-J) Stents
1.2.4 Iodine-125 Radioactive Stents
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Lithotripsy
1.3.2 Ureteroscopy
1.3.3 Ureteroenoscopy
1.3.4 Percutaneous Nephrolithotomy
1.3.5 Angiography
1.3.6 Neointimal Hyperplasia
1.3.7 Esophageal Cancer
1.3.8 Biliary Cancer
1.3.9 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 C.R. Bard, Inc.
2.1.1 Business Overview
2.1.2 Radioactive Stents Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 C.R. Bard, Inc. Radioactive Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Cook Medical Inc.
2.2.1 Business Overview
2.2.2 Radioactive Stents Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Cook Medical Inc. Radioactive Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Medline Industries Ltd
2.3.1 Business Overview
2.3.2 Radioactive Stents Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Medline Industries Ltd Radioactive Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pnn Medical A/S
2.4.1 Business Overview
2.4.2 Radioactive Stents Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pnn Medical A/S Radioactive Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Allium Medical Solutions Ltd.
2.5.1 Business Overview
2.5.2 Radioactive Stents Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Allium Medical Solutions Ltd. Radioactive Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 APC Cardiovascular Ltd.
2.6.1 Business Overview
2.6.2 Radioactive Stents Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 APC Cardiovascular Ltd. Radioactive Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Micro-Tech Pvt. Ltd.
2.7.1 Business Overview
2.7.2 Radioactive Stents Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Micro-Tech Pvt. Ltd. Radioactive Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Changzhou Zhiye Co Ltd.
2.8.1 Business Overview
2.8.2 Radioactive Stents Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Changzhou Zhiye Co Ltd. Radioactive Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Aetna Inc.
2.9.1 Business Overview
2.9.2 Radioactive Stents Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Aetna Inc. Radioactive Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Abbott Laboratories
2.10.1 Business Overview
2.10.2 Radioactive Stents Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Abbott Laboratories Radioactive Stents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Radioactive Stents Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Radioactive Stents Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Radioactive Stents Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Radioactive Stents Manufacturer Market Share in 2017
3.3.2 Top 6 Radioactive Stents Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Radioactive Stents Market Analysis by Regions
4.1 Global Radioactive Stents Sales, Revenue and Market Share by Regions
4.1.1 Global Radioactive Stents Sales and Market Share by Regions (2013-2018)
4.1.2 Global Radioactive Stents Revenue and Market Share by Regions (2013-2018)
4.2 North America Radioactive Stents Sales and Growth Rate (2013-2018)
4.3 Europe Radioactive Stents Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Radioactive Stents Sales and Growth Rate (2013-2018)
4.5 South America Radioactive Stents Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Radioactive Stents Sales and Growth Rate (2013-2018)
5 North America Radioactive Stents by Countries
5.1 North America Radioactive Stents Sales, Revenue and Market Share by Countries
5.1.1 North America Radioactive Stents Sales and Market Share by Countries (2013-2018)
5.1.2 North America Radioactive Stents Revenue and Market Share by Countries (2013-2018)
5.2 United States Radioactive Stents Sales and Growth Rate (2013-2018)
5.3 Canada Radioactive Stents Sales and Growth Rate (2013-2018)
5.4 Mexico Radioactive Stents Sales and Growth Rate (2013-2018)
6 Europe Radioactive Stents by Countries
6.1 Europe Radioactive Stents Sales, Revenue and Market Share by Countries
6.1.1 Europe Radioactive Stents Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Radioactive Stents Revenue and Market Share by Countries (2013-2018)
6.2 Germany Radioactive Stents Sales and Growth Rate (2013-2018)
6.3 UK Radioactive Stents Sales and Growth Rate (2013-2018)
6.4 France Radioactive Stents Sales and Growth Rate (2013-2018)
6.5 Russia Radioactive Stents Sales and Growth Rate (2013-2018)
6.6 Italy Radioactive Stents Sales and Growth Rate (2013-2018)
7 Asia-Pacific Radioactive Stents by Countries
7.1 Asia-Pacific Radioactive Stents Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Radioactive Stents Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Radioactive Stents Revenue and Market Share by Countries (2013-2018)
7.2 China Radioactive Stents Sales and Growth Rate (2013-2018)
7.3 Japan Radioactive Stents Sales and Growth Rate (2013-2018)
7.4 Korea Radioactive Stents Sales and Growth Rate (2013-2018)
7.5 India Radioactive Stents Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Radioactive Stents Sales and Growth Rate (2013-2018)
8 South America Radioactive Stents by Countries
8.1 South America Radioactive Stents Sales, Revenue and Market Share by Countries
8.1.1 South America Radioactive Stents Sales and Market Share by Countries (2013-2018)
8.1.2 South America Radioactive Stents Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Radioactive Stents Sales and Growth Rate (2013-2018)
8.3 Argentina Radioactive Stents Sales and Growth Rate (2013-2018)
8.4 Colombia Radioactive Stents Sales and Growth Rate (2013-2018)
9 Middle East and Africa Radioactive Stents by Countries
9.1 Middle East and Africa Radioactive Stents Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Radioactive Stents Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Radioactive Stents Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Radioactive Stents Sales and Growth Rate (2013-2018)
9.3 UAE Radioactive Stents Sales and Growth Rate (2013-2018)
9.4 Egypt Radioactive Stents Sales and Growth Rate (2013-2018)
9.5 Nigeria Radioactive Stents Sales and Growth Rate (2013-2018)
9.6 South Africa Radioactive Stents Sales and Growth Rate (2013-2018)
10 Global Radioactive Stents Market Segment by Type
10.1 Global Radioactive Stents Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Radioactive Stents Sales and Market Share by Type (2013-2018)
10.1.2 Global Radioactive Stents Revenue and Market Share by Type (2013-2018)
10.2 Retrograde Stents Sales Growth and Price
10.2.1 Global Retrograde Stents Sales Growth (2013-2018)
10.2.2 Global Retrograde Stents Price (2013-2018)
10.3 Antegrade Stents Sales Growth and Price
10.3.1 Global Antegrade Stents Sales Growth (2013-2018)
10.3.2 Global Antegrade Stents Price (2013-2018)
10.4 Internal (Double-J) Stents Sales Growth and Price
10.4.1 Global Internal (Double-J) Stents Sales Growth (2013-2018)
10.4.2 Global Internal (Double-J) Stents Price (2013-2018)
10.5 Iodine-125 Radioactive Stents Sales Growth and Price
10.5.1 Global Iodine-125 Radioactive Stents Sales Growth (2013-2018)
10.5.2 Global Iodine-125 Radioactive Stents Price (2013-2018)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2013-2018)
10.6.2 Global Others Price (2013-2018)
11 Global Radioactive Stents Market Segment by Application
11.1 Global Radioactive Stents Sales Market Share by Application (2013-2018)
11.2 Lithotripsy Sales Growth (2013-2018)
11.3 Ureteroscopy Sales Growth (2013-2018)
11.4 Ureteroenoscopy Sales Growth (2013-2018)
11.5 Percutaneous Nephrolithotomy Sales Growth (2013-2018)
11.6 Angiography Sales Growth (2013-2018)
11.7 Neointimal Hyperplasia Sales Growth (2013-2018)
11.8 Esophageal Cancer Sales Growth (2013-2018)
11.9 Biliary Cancer Sales Growth (2013-2018)
11.10 Others Sales Growth (2013-2018)
12 Radioactive Stents Market Forecast (2018-2023)
12.1 Global Radioactive Stents Sales, Revenue and Growth Rate (2018-2023)
12.2 Radioactive Stents Market Forecast by Regions (2018-2023)
12.2.1 North America Radioactive Stents Market Forecast (2018-2023)
12.2.2 Europe Radioactive Stents Market Forecast (2018-2023)
12.2.3 Asia-Pacific Radioactive Stents Market Forecast (2018-2023)
12.2.4 South America Radioactive Stents Market Forecast (2018-2023)
12.2.5 Middle East and Africa Radioactive Stents Market Forecast (2018-2023)
12.3 Radioactive Stents Market Forecast by Type (2018-2023)
12.3.1 Global Radioactive Stents Sales Forecast by Type (2018-2023)
12.3.2 Global Radioactive Stents Market Share Forecast by Type (2018-2023)
12.4 Radioactive Stents Market Forecast by Application (2018-2023)
12.4.1 Global Radioactive Stents Sales Forecast by Application (2018-2023)
12.4.2 Global Radioactive Stents Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Radioactive Stents Picture
Table Product Specifications of Radioactive Stents
Figure Global Sales Market Share of Radioactive Stents by Types in 2017
Ta
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
